Fuller McCabe, MD
Orthopaedic Surgery · Tuscaloosa, ALNPI 1932593548
Payments from drug & device makers
Across 50 payments — averaging $395.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- ALON Medical Technology$1K
- Johnson & Johnson$1K
- Medical Device Business Services, Inc.$815
- Zimmer Biomet$593
- Amgen$120
- plus $422 from 9 others
What the payments were for
- Consulting fees$6914%
- Travel & lodging$2501%
- Food & beverage$2,54813%
- Education$16,26082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $15,465 |
| ALON Medical Technology | 1 | $1,260 |
| Johnson & Johnson(3 entities) | 18 | $1,075 |
| Medical Device Business Services, Inc. | 2 | $815 |
| Zimmer Biomet | 7 | $593 |
| Amgen | 2 | $120 |
| Conformis, Inc. | 1 | $85 |
| Stryker | 1 | $71 |
| Biocomposites Inc | 1 | $70 |
| Microport Orthopedics Inc | 1 | $68 |
| Sanara Medtech Inc. | 1 | $42 |
| Alvogen Inc | 1 | $29 |
| Bioventus LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,750 in reported general payments places this provider in the 80th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 194 | $1,140 |
| Cefadroxil | 163 | $1,082 |
| Levofloxacin | 12 | $698 |
| Celecoxib | 24 | $663 |
| Tramadol Hcl | 234 | $614 |
| Ondansetron Hcl | 138 | $553 |
| Diclofenac Sodium | 28 | $477 |
| Methylprednisolone | 52 | $352 |
| Pregabalin | 27 | $281 |
| Gabapentin | 31 | $253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $191 |
| Meloxicam | 76 | $157 |
| Amoxicillin | 28 | $35 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tuscaloosa
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- James SmithGadsden$2.7M
- Herrick SiegelBirmingham$1.3M
- Paul CanaleDaphne$609K
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$219K
- Lawrence LemakVestavia$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.